Inflammatory bowel disease and celiac disease: Overlaps and differences

World Journal of Gastroenterology

Volumn 20, Issue 17, 2014, Pages 4846-4856

  Pascual, Virginia ^a   Dieli Crimi, Romina ^a   López Palacios, Natalia ^a   Bodas, Andrés ^a   Medrano, Luz María ^a   Núñez, Concepción ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Disease susceptibility; Gene environment interaction; Immune system; Inflammation; Inflammatory bowel disease; Microbiota

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; AZATHIOPRINE; ENDOMYSIUM ANTIBODY; GLUTEN; HLA DQ2 ANTIGEN; INFLIXIMAB; MERCAPTOPURINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2 ANTIBODY; UNCLASSIFIED DRUG; VITAMIN D; BIOLOGICAL MARKER;

ABDOMINAL PAIN; ANTIGEN PRESENTATION; APPENDECTOMY; ARTICLE; CELIAC DISEASE; CLINICAL FEATURE; CROHN DISEASE; DIARRHEA; DYSBIOSIS; ENVIRONMENTAL FACTOR; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUTEN FREE DIET; HEREDITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; META ANALYSIS (TOPIC); NONHUMAN; SHORT STATURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; ADAPTIVE IMMUNITY; AUTOIMMUNITY; BLOOD; COLITIS, ULCERATIVE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ONSET AGE; PHENOTYPE; PROGNOSIS; RISK FACTOR;

ADAPTIVE IMMUNITY; AGE OF ONSET; AUTOIMMUNITY; BIOLOGICAL MARKERS; CELIAC DISEASE; COLITIS, ULCERATIVE; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; PHENOTYPE; PROGNOSIS; RISK FACTORS;

EID: 84899865480     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i17.4846     Document Type: Article

References (88)

1. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-292 [PMID: 12578508 DOI: 10.1001/archinte.163.3.286]
2. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Höpfl P, Knip M. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003; 348: 2517-2524 [PMID: 12815137 DOI: 10.1056/NEJMoa021687]
3. Accomando S, Cataldo F. The global village of celiac disease. Dig Liver Dis 2004; 36: 492-498 [PMID: 15285531 DOI: 10.1016/j.dld.2004.01.026]
4. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012; 18: 6036-6059 [PMID: 23155333 DOI: 10.3748/ wjg.v18.i42.6036]
5. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 [PMID: 15168363 DOI: 10.1053/j.gastro.2004.01.063]
6. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, Gelfond D, Puppa E, Sferruzza A, Fasano A. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010; 42: 530-538 [PMID: 20868314 DOI: 10.3109/07853890.2010.514285]
7. Malmborg P, Grahnquist L, Lindholm J, Montgomery S, Hildebrand H. Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007. J Pediatr Gastroenterol Nutr 2013; 57: 29-34 [PMID: 23459320 DOI: 10.1097/MPG.0b013e31828f21b4]
8. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, Zinsmeister AR, Melton LJ, Murray JA. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137: 88-93 [PMID: 19362553 DOI: 10.1053/ j.gastro.2009.03.059]
9. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, Lohi O, Bravi E, Gasparin M, Reunanen A, Mäki M. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26: 1217-1225 [PMID: 17944736 DOI: 10.1111/j.1365-2036.2007.03502.x]
10. Ivarsson A, Persson LA, Nyström L, Hernell O. The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors. Eur J Epidemiol 2003; 18: 677-684 [PMID: 12952142 DOI: 10.1023/A:1024873630588]
11. Green PHR SN, Panagi SG, Goldstein SL, Mcmahon DJ, Absan H, Neugut AI. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001; 96: 126-131 [PMID: 11197241 DOI: 10.1111/j.1572-0241.2001.03462. x]
12. Mariné M, Farre C, Alsina M, Vilar P, Cortijo M, Salas A, Fernández-Bañares F, Rosinach M, Santaolalla R, Loras C, Marquès T, Cusí V, Hernández MI, Carrasco A, Ribes J, Viver JM, Esteve M. The prevalence of coeliac disease is significantly higher in children compared with adults. Aliment Pharmacol Ther 2011; 33: 477-486 [PMID: 21166832 DOI: 10.1111/j.1365-2036.2010.04543.x]
13. Cottone M, Cappello M, Puleo A, Cipolla C, Filippazzo MG. Familial association of Crohn's and coeliac diseases. Lancet 1989; 2: 338 [PMID: 2569142 DOI: 10.1016/ S0140-6736(89)90527-8]
14. Cottone M, Marrone C, Casà A, Oliva L, Orlando A, Calabrese E, Martorana G, Pagliaro L. Familial occurrence of inflammatory bowel disease in celiac disease. Inflamm Bowel Dis 2003; 9: 321-323 [PMID: 14555916 DOI: 10.1097/00054725-200309000-00006]
15. Euler AR, Ament ME. Celiac sprue and Crohn's disease: an association causing severe growth retardation. Gastroenterology 1977; 72: 729-731 [PMID: 838230]
16. Gillberg R, Dotevall G, Ahrén C. Chronic inflammatory bowel disease in patients with coeliac disease. Scand J Gastroenterol 1982; 17: 491-496 [PMID: 7134876 DOI: 10.3109/00365 528209182237]
17. Kitis G, Holmes GK, Cooper BT, Thompson H, Allan RN. Association of coeliac disease and inflammatory bowel disease. Gut 1980; 21: 636-641 [PMID: 7429328 DOI: 10.1136/ gut.21.7.636]
18. Yang A, Chen Y, Scherl E, Neugut AI, Bhagat G, Green PH. Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis 2005; 11: 528-532 [PMID: 15905699 DOI: 10.1097/01.MIB.0000161308.65951.db]
19. Casella G, D'Incà R, Oliva L, Daperno M, Saladino V, Zoli G, Annese V, Fries W, Cortellezzi C. Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study. Dig Liver Dis 2010; 42: 175-178 [PMID: 19786375 DOI: 10.1016/j.dld.2009.08.005]
20. IBD Working Group of the European Society for Paediatric Gastroenterology HaN. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7 [PMID: 15990620 DOI: 10.1097/01.MPG.0000163736.30261.82]
21. Freeman HJ. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. Can J Gastroenterol 2007; 21: 363-366 [PMID: 17571169]
22. Ezri J, Marques-Vidal P, Nydegger A. Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease. Digestion 2012; 85: 308-319 [PMID: 22688404 DOI: 10.1159/000336766]
23. Szigethy E, McLafferty L, Goyal A. Inflammatory bowel disease. Pediatr Clin North Am 2011; 58: 903-920, x-xi [PMID: 21855713 DOI: 10.1016/j.pcl.2011.06.007]
24. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19 [PMID: 15625418 DOI: 10.1097/00005176-200501000-00001]
25. Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol 2012; 34: 473-478 [PMID: 22526468 DOI: 10.1007/s00281-012-0311-2]
26. Encinas A, Cerezo E, Cano JM, Segura JM, Suárez J, Muro J, Ortiz Vázquez J. Form of presentation and clinical manifestations of Crohn disease in our environment. Rev Esp Enferm Apar Dig 1985; 67: 15-24 [PMID: 3975459]
27. Rodrigo Sáez L. Celiac disease in the adult. Rev Esp Enferm Dig 2006; 98: 397-407 [PMID: 16948539 DOI: 10.4321/ S1130-01082006000600001]
28. Malamut G, Cellier C. Refractory coeliac disease. Curr Opin Oncol 2013; 25: 445-451 [PMID: 23942290 DOI: 10.1097/01. cco.0000432526.47228.b6]
29. Ciobanu L, Pascu O, Iobagiu S, Damian D, Dumitru E, Tantau M. Unknown complicated celiac disease as an unexpected finding in patients investigated with capsule endoscopy for Crohn's disease. A case series. J Gastrointestin Liver Dis 2013; 22: 97-100 [PMID: 23539398]
30. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Mäki M, Ribes-Koninckx C, Ventura A, Zimmer KP. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-160 [PMID: 22197856 DOI: 10.1097/MPG.0b013e31821a23d0]
31. Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci 2003; 48: 2360-2365 [PMID: 14714625 DOI: 10.1023/B:DDAS.0000007875.72256.e8]
32. Dahele AV, Aldhous MC, Humphreys K, Ghosh S. Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases. QJM 2001; 94: 195-205 [PMID: 11294962 DOI: 10.1093/qjmed/94.4.195]
33. Ribeiro-Cabral VL, da-Silva-Patrício FR, Ambrogini-Junior O, Jankiel-Miszputen S. Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn's disease and autoimmune diabetes. Rev Esp Enferm Dig 2011; 103: 453-457 [PMID: 21951113 DOI: 10.4321/S1130-01082011000900003]
34. Tavakkoli H, Haghdani S, Adilipour H, Daghaghzadeh H, Minakari M, Adibi P, Ahmadi K, Emami MH. Serologic celiac disease in patients with inflammatory bowel disease. J Res Med Sci 2012; 17: 154-158 [PMID: 23264789]
35. Tursi A, Giorgetti GM, Brandimarte G, Elisei W. High prevalence of celiac disease among patients affected by Crohn's disease. Inflamm Bowel Dis 2005; 11: 662-666 [PMID: 15973121 DOI: 10.1097/01.MIB.0000164195.75207.1e]
36. Kotze LM, Nisihara RM, Utiyama SR, Kotze PG, Theiss PM, Olandoski M. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease. Arq Gastroenterol 2010; 47: 242-245 [PMID: 21140083 DOI: 10.1590/S0004-28032010000300006]
37. Homsak E, Micetić-Turk D, Bozic B. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Wien Klin Wochenschr 2010; 122 Suppl 2: 19-25 [PMID: 20517666 DOI: 10.1007/ s00508-010-1344-y]
38. Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, Taki I, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101: 2333-2340 [PMID: 17032199 DOI: 10.1111/j.1572-0241.2006.00741.x]
39. Ruggeri C, La Masa AT, Rudi S, Squadrito G, Di Pasquale G, Maimone S, Caccamo G, Pellegrino S, Raimondo G, Magazzù G. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection. Dig Dis Sci 2008; 53: 2151-2155 [PMID: 18231858 DOI: 10.1007/ s10620-007-0146-1]
40. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 2006; 91: 39-43 [PMID: 16287899 DOI: 10.1136/ adc.2005.082016]
41. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-767 [PMID: 7907734 DOI: 10.1016/ S0140-6736(94)91841-4]
42. Rook GA. Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis 2011; 29: 144-153 [PMID: 21734378 DOI: 10.1159/000323877]
43. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007; 13: 6134-6139 [PMID: 18069751 DOI: 10.3748/wjg.13.6134]
44. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004; 18: 481-496 [PMID: 15157822 DOI: 10.1016/j.bpg.2003.12.003]
45. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 2000; 95: 171-176 [PMID: 10638578 DOI: 10.1111/ j.1572-0241.2000.01680.x]
46. Naganuma M, Iizuka B, Torii A, Ogihara T, Kawamura Y, Ichinose M, Kojima Y, Hibi T. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123-1126 [PMID: 11316158 DOI: 10.1111/j.1572-0241.2001.03757.x]
47. Ananthakrishnan AN. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2013; 9: 367-374 [PMID: 23935543]
48. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206: 260-276 [PMID: 16048554 DOI: 10.1111/ j.0105-2896.2005.00291.x]
49. Harper PH, Lee EC, Kettlewell MG, Bennett MK, Jewell DP. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985; 26: 279-284 [PMID: 3972275 DOI: 10.1136/ gut.26.3.279]
50. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997; 148: 567-576 [PMID: 9588836 DOI: 10.1016/S0923-2494(98)80151-X]
51. De Cruz P, Prideaux L, Wagner J, Ng SC, McSweeney C, Kirkwood C, Morrison M, Kamm MA. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 372-390 [PMID: 21604329 DOI: 10.1002/ibd.21751]
52. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis as a prerequisite for IBD. Gut 2004; 53: 1057 [PMID: 15194668]
53. Nistal E, Caminero A, Herrán AR, Arias L, Vivas S, de Morales JM, Calleja S, de Miera LE, Arroyo P, Casqueiro J. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm Bowel Dis 2012; 18: 649-656 [PMID: 21826768 DOI: 10.1002/ibd.21830]
54. Sanz Y, De Pama G, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 2011; 30: 207-218 [PMID: 21787226 DOI: 10.3109/08830185.20 11.599084]
55. Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, Mäki M, Mättö J. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 2013; 19: 934-941 [PMID: 23478804 DOI: 10.1097/ MIB.0b013e31828029a9]
56. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124 [PMID: 23128233 DOI: 10.1038/nature11582]
57. Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA. The first large population based twin study of coeliac disease. Gut 2002; 50: 624-628 [PMID: 11950806 DOI: 10.1136/gut.50.5.624]
58. Halfvarson J, Bodin L, Tysk C, Lindberg E, Järnerot G. Inflammatory bowel disease in a Swedish twin cohort: a longterm follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767-1773 [PMID: 12806610 DOI: 10.1016/S0016-5085(03)00385-8]
59. Festen EA, Goyette P, Green T, Boucher G, Beauchamp C, Trynka G, Dubois PC, Lagacé C, Stokkers PC, Hommes DW, Barisani D, Palmieri O, Annese V, van Heel DA, Weersma RK, Daly MJ, Wijmenga C, Rioux JD. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet 2011; 7: e1001283 [PMID: 21298027 DOI: 10.1371/journal.pgen.1001283]
60. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, Bakker SF, Bardella MT, Bhaw-Rosun L, Castillejo G, de la Concha EG, de Almeida RC, Dias KR, van Diemen CC, Dubois PC, Duerr RH, Edkins S, Franke L, Fransen K, Gutierrez J, Heap GA, Hrdlickova B, Hunt S, Plaza Izurieta L, Izzo V, Joosten LA, Langford C, Mazzilli MC, Mein CA, Midah V, Mitrovic M, Mora B, Morelli M, Nutland S, Núñez C, Onengut-Gumuscu S, Pearce K, Platteel M, Polanco I, Potter S, Ribes-Koninckx C, Ricaño-Ponce I, Rich SS, Rybak A, Santiago JL, Senapati S, Sood A, Szajewska H, Troncone R, Varadé J, Wallace C, Wolters VM, Zhernakova A, Thelma BK, Cukrowska B, Urcelay E, Bilbao JR, Mearin ML, Barisani D, Barrett JC, Plagnol V, Deloukas P, Wijmenga C, van Heel DA. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011; 43: 1193-1201 [PMID: 22057235 DOI: 10.1038/ ng.998]
61. Hunt KA, Mistry V, Bockett NA, Ahmad T, Ban M, Barker JN, Barrett JC, Blackburn H, Brand O, Burren O, Capon F, Compston A, Gough SC, Jostins L, Kong Y, Lee JC, Lek M, MacArthur DG, Mansfield JC, Mathew CG, Mein CA, Mirza M, Nutland S, Onengut-Gumuscu S, Papouli E, Parkes M, Rich SS, Sawcer S, Satsangi J, Simmonds MJ, Trembath RC, Walker NM, Wozniak E, Todd JA, Simpson MA, Plagnol V, van Heel DA. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013; 498: 232-235 [PMID: 23698362 DOI: 10.1038/nature12170]
62. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-1217 [PMID: 8622450 DOI: 10.1016/S0140-6736(96)90734-5]
63. Julià A, Domènech E, Ricart E, Tortosa R, García-Sánchez V, Gisbert JP, Nos Mateu P, Gutiérrez A, Gomollón F, Mendoza JL, Garcia-Planella E, Barreiro-de Acosta M, Muñoz F, Vera M, Saro C, Esteve M, Andreu M, Alonso A, López-Lasanta M, Codó L, Gelpí JL, García-Montero AC, Bertranpetit J, Absher D, Panés J, Marsal S. A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300. Gut 2013; 62: 1440-1445 [PMID: 22936669 DOI: 10.1136/ gutjnl-2012-302865]
64. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361: 2033-2045 [PMID: 19890111 DOI: 10.1056/NEJMoa0907206]
65. Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KE, Sjöström H, Sollid LM. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-717 [PMID: 9623982 DOI: 10.1038/nm0698-713]
66. Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275-2279 [PMID: 12351792 DOI: 10.1126/science.1074129]
67. Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Self Nonself 2010; 1: 299-309 [PMID: 21487504 DOI: 10.4161/self.1.4.13560]
68. Medrano LM, García-Magariños M, Dema B, Espino L, Maluenda C, Polanco I, Figueredo MÁ, Fernández-Arquero M, Núñez C. Th17-related genes and celiac disease susceptibility. PLoS One 2012; 7: e31244 [PMID: 22359581 DOI: 10.1371/ journal.pone.0031244]
69. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051-1057 [PMID: 18563156 DOI: 10.1038/nature07036]
70. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-1549 [PMID: 12047962 DOI: 10.1016/S0140-6736(02)08512-4]
71. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029-1035 [PMID: 9321530 DOI: 10.1056/NEJM199710093371502]
72. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-2476 [PMID: 16339095 DOI: 10.1056/NEJMoa050516]
73. Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006; 130: 323-333; quiz 591 [PMID: 16472588 DOI: 10.1053/ j.gastro.2005.11.030]
74. Sandborn WJ, Hanauer SB, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh DG, Panaccione R, Wolf D, Kent JD, Bittle B, Li J, Pollack PF. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut 2007; 56: 1232-1239 [PMID: 17299059 DOI: 10.1136/gut.2006.106781]
75. Lichtenstein GR, Panaccione R, Mallarkey G. Efficacy and safety of adalimumab in Crohn's disease. Therap Adv Gastroenterol 2008; 1: 43-50 [PMID: 21180513 DOI: 10.1177/1756283 X08092548]
76. Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003; 348: 601-608 [PMID: 12584368 DOI: 10.1056/ NEJMoa020888]
77. Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, Schulzke JD, Boerner N, Kueppers B, Emmrich J, Mescheder A, Schwertschlag U, Shapiro M, Stange EF. Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease. Am J Gastroenterol 2006; 101: 793-797 [PMID: 16635225 DOI: 10.1111/j.1572-0241.2005.00356.x]
78. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004; 126: 989-996; discussion 947 [PMID: 15057738 DOI: 10.1053/ j.gastro.2004.01.012]
79. Kasran A, Boon L, Wortel CH, Hogezand RA, Schreiber S, Goldin E, Boer M, Geboes K, Rutgeerts P, Ceuppens JL. Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease. Aliment Pharmacol Ther 2005; 22: 111-122 [PMID: 16011669 DOI: 10.1111/j.1365-2036.2005.02526.x]
80. Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med 2012; 367: 1519-1528 [PMID: 23075178 DOI: 10.1056/NEJMoa1203572]
81. Krauss N, Schuppan D. Monitoring nonresponsive patients who have celiac disease. Gastrointest Endosc Clin N Am 2006; 16: 317-327 [PMID: 16644460 DOI: 10.1016/j.giec.2006.03.005]
82. Al-toma A, Verbeek WH, Mulder CJ. The management of complicated celiac disease. Dig Dis 2007; 25: 230-236 [PMID: 17827946 DOI: 10.1159/000103891]
83. Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B, Macintyre E, Cerf-Bensussan N, Brousse N. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000; 356: 203-208 [PMID: 10963198 DOI: 10.1016/ S0140-6736(00)02481-8]
84. Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, Bouhnik Y, Colombel JF, Delchier JC, Allez M, Cosnes J, Lavergne-Slove A, Meresse B, Trinquart L, Macintyre E, Radford-Weiss I, Hermine O, Brousse N, Cerf-Bensussan N, Cellier C. Presentation and long-term followup of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009; 136: 81-90 [PMID: 19014942 DOI: 10.1053/j.gastro.2008.09.069]
85. Goerres MS, Meijer JW, Wahab PJ, Kerckhaert JA, Groenen PJ, Van Krieken JH, Mulder CJ. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003; 18: 487-494 [PMID: 12950421 DOI: 10.1046/j.1365-2036.2003.01687.x]
86. Dray X, Joly F, Lavergne-Slove A, Treton X, Bouhnik Y, Messing B. A severe but reversible refractory sprue. Gut 2006; 55: 1210-1211 [PMID: 16849355 DOI: 10.1136/gut.2005.089987]
87. Al-Toma A, Goerres MS, Meijer JW, von Blomberg BM, Wahab PJ, Kerckhaert JA, Mulder CJ. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006; 4: 1322-1327; quiz 1300 [PMID: 16979946]
88. Rashtak S, Murray JA. Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther 2012; 35: 768-781 [PMID: 22324389 DOI: 10.1111/j.1365-2036.2012.05013.x]